AI Shortens Sweetener R&D, Offers Novel Compounds for Sugar Reduction

London, United Kingdom — 22 October 2024

Artificial intelligence is fundamentally reshaping sweetener innovation, pivoting from protracted trial-and-error discovery to targeted identification of new functional compounds. Effendi Leonard, CEO of 2nd Nature, highlights AI's capacity to uncover sweet molecules in agricultural products previously overlooked by traditional screening methods, offering new avenues for sugar reduction.

Historically, sweetener development involved sequential, multi-year steps for discovery, sensory prediction, and formulation optimisation. AI consolidates these processes, predicting taste, texture, stability, and functional performance early in molecular identification. This integration significantly alters the economics of new sweetening system development, enabling companies to identify commercially viable candidates faster and reduce overall R&D expenditure.

The current high-intensity sweetener market, while dominated by stevia and monk fruit, faces limitations regarding aftertaste and sourcing. AI-driven platforms are identifying novel sweet compounds from major crops, not reformulations of existing ingredients, but genuinely new molecules found in agricultural processing streams. This broadens the palette available to formulators seeking improved sensory profiles and diversified supply chains.

While AI provides high-confidence shortlists of promising candidates, it does not eliminate the need for sensory science. Predictive models serve as a critical starting point, reducing the number of samples requiring manual evaluation and application testing. This efficiency allows R&D teams to focus resources on the most viable compounds, accelerating product development cycles without compromising validation integrity.

A significant advantage of AI in sweetener development is the ability to design compounds tailored for specific applications. Instead of adapting a single ingredient across diverse product categories, AI facilitates matching candidate compounds to requirements in beverages, dairy, or bakery products earlier in the development phase. This bespoke approach promises more effective sugar reduction solutions and enhanced product performance.

2nd Nature’s strategy for its AI-discovered sweeteners prioritises blending to achieve practical sugar reduction. Recognising that sugar provides more than just sweetness (e.g., bulk, texture, mouthfeel), novel ingredients are designed to work alongside existing sweetening systems, allowing reductions without compromising product integrity. Initial commercial sampling shows particular interest in beverage and dairy applications, which are highly sensitive to aftertaste and sensory performance.

The path from AI discovery to market still involves critical challenges beyond molecular identification. Regulatory approval, manufacturing scalability, and consistent supply reliability remain paramount. These factors dictate the timeline for widespread adoption, irrespective of the speed of initial discovery, underscoring the need for a comprehensive 'Discover, Develop, Deploy' framework.

What this means for United Kingdom

UK brand owners and manufacturers gain an opportunity to differentiate products through novel, next-generation sugar reduction solutions that offer superior taste profiles and clean-label appeal. Expect shorter ingredient procurement lead times for new sweetener development, potentially reducing a 24-month R&D cycle to 6-9 months for early adopters. However, new ingredient regulatory approval via the UK's novel foods process (FSA) is non-negotiable and can add 12-18 months to market entry, even with rapid discovery. Manufacturers should assess supply chain resilience and MOQ requirements for novel ingredients to mitigate reliance on single-source suppliers and ensure cost-effective production volumes.

For more on UK formulation and manufacturing best practice, learn more at Supplement Factory.